Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%) Dr. Reddys Laboratories informs about company updates
Date: 14-06-2017Dr. Reddys Laboratories has informed about Dr. Reddys API manufacturing plant at Miryalaguda receives EIR from the US FDA as closure of Audit.
The above information is a part of company’s filings submitted to BSE.